{
  "id": "9f80849cc741f849",
  "title": "STAT+: Pharmalittle: We\u2019re reading about the U.S. launch of a Wegovy pill, a Chinese biotech incubator, and more",
  "description": "Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per month for self-paying patients",
  "content": "Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per month for self-paying patients",
  "source": "STAT",
  "source_url": "https://www.statnews.com/pharmalot/2026/01/05/novo-obesity-wegovy-china-biotech-gsk-sanofi-pbm/?utm_campaign=rss",
  "published_at": "2026-01-05T14:25:57+00:00",
  "fetched_at": "2026-01-06T00:23:36.488656+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Pharmalittle: We\u2019re reading about the U.S. launch of a Wegovy pill, a Chinese biotech incubator, and more",
    "description": "Novo Nordisk is launching its once-daily Wegovy pill in the U.S. on Monday, offering 1.5- and 4-milligram doses at $149 per month for self-paying patients",
    "url": "https://www.statnews.com/pharmalot/2026/01/05/novo-obesity-wegovy-china-biotech-gsk-sanofi-pbm/?utm_campaign=rss",
    "published": "2026-01-05T14:25:57+00:00",
    "source": "STAT"
  }
}